June 8, 2026—Remote Medical Technologies has achieved SOC 2 type 2 certification. The certification verifies that the company’s controls related to security, availability, and confidentiality are properly designed and operate effectively over an extended time.
“This certification represents a significant milestone for RMT and reinforces our long-standing commitment to protecting patient data, supporting hospital IT requirements, and maintaining the highest operational standards,” Don Marchon, founder and CEO at RMT, said in a statement. “Our health care partners trust us in time-critical clinical environments, and SOC 2 type 2 certification provides independent validation that our systems, processes, and controls meet rigorous industry expectations.”
RMT’s telepathology platforms include the ROSE Now for rapid onsite cytology evaluation and Section Now for frozen section assessments.